19 results on '"Gardini, Andrea Casadei"'
Search Results
2. Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma
3. Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib
4. Predicting cardiovascular risk in patients with HCC receiving tyrosine kinase inhibitors: comparison of two different scores
5. The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis
6. Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis
7. Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma
8. THU-145 - Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments
9. THU-131 - Incidence and risk factors of esophagogastric varices bleeding in patients with advanced hepatocellular carcinoma treated with lenvatinib
10. FRI-287 - Predicting cardiovascular risk in patients with HCC receiving tyrosine kinase inhibitors: comparison of two different scores
11. LBO-04 - Deep learning predicts sensitivity to atezolizumab-bevacizumab from digital slides of hepatocellular carcinoma
12. SAT180 - The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis
13. FRI554 - Proteomic analysis of bile in the rat thioacetamide model reveals new mechanisms in human cholangiocarcinogenesis
14. FRI222 - Plasma cell-free DNA methylation as biomarker for hepatocellular carcinoma
15. SAT-456-New multi inflammation indicators in advanced hepatocellular carcinoma patients receiving sorafenib
16. THU-448-Multicentric prospettive study of validation of angiogenesis-related gene polymorphisms in hepatocellular carcinoma patients treated with sorafenib: Interim analysis of INNOVATE study
17. PS-043-Dual targeting of G9a and DNM-methyltransferase-1 for the treatment of experimental cholangiocarcinoma
18. SAT-455-Efficacy of sorafenib and lenvatinib for hepatitis status: a network meta-analysis of phase III trial
19. FRI-474-AGT gene polymorphisms predict early dose modification of sorafenib for dermatological adverse events: towards tailored medicine for patients with hepatocellular carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.